Sculptor Capital LP Eli Lilly & CO Transaction History

Sculptor Capital LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$278.73 - $327.27 $34.9 Million - $40.9 Million	-125,121 Reduced 86.68%	19,222 $6.23 Million
Q1 2022 May 13, 2022	BUY	$234.69 - $291.66 $12.8 Million - $16 Million	54,722 Added 61.06%	144,343 $41.3 Million
Q4 2021 Feb 11, 2022	BUY	$224.85 - $279.04 $20.2 Million - $25 Million	89,621 New	89,621 $24.8 Million

4,010

752M

8.27M

10.5M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $760B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of Sculptor Capital LP, based on Form 13F filings with the SEC.

Stay updated on Sculptor Capital LP with notifications on news.